Company Overview

Vext Science, Inc. is a U.S.-focused cannabis company operating primarily in the regulated cannabis cultivation, manufacturing, and retail industries. The company is structured as a multi-state operator with an emphasis on vertically integrated operations, generating revenue through the cultivation of cannabis, production of branded cannabis products, and direct-to-consumer sales via licensed dispensaries. Its core revenue drivers are retail dispensary sales and wholesale distribution of in-house manufactured products.

Originally founded as Vapen MJ, the company rebranded to Vext Science following a corporate restructuring to align its identity with broader cannabis science and consumer branding initiatives. The company has positioned itself as an operationally disciplined operator with a focus on limited-license markets, seeking to control costs and maintain regulatory compliance while expanding retail footprint and production capacity.

Business Operations

Vext Science operates through vertically integrated business segments including Cultivation, Manufacturing, and Retail Dispensaries, with the majority of revenue derived from retail sales to medical and adult-use cannabis consumers. Its operations are anchored in Arizona, where it owns and operates cultivation facilities, production assets, and multiple dispensaries, allowing the company to capture margin across the value chain.

The company controls proprietary cultivation processes and branded product lines, with distribution occurring through both company-owned dispensaries and wholesale channels. Vext Science operates through wholly owned subsidiaries established to hold state-specific licenses, and it has historically pursued selective partnerships related to branding, retail locations, and local operations. Data inconclusive based on available public sources regarding any active joint ventures outside its core licensed subsidiaries.

Strategic Position & Investments

Vext Science’s strategy centers on disciplined expansion in limited-license cannabis markets, prioritizing operational efficiency, vertical integration, and balance sheet management over rapid geographic sprawl. Growth initiatives have historically focused on expanding dispensary count within existing states, increasing cultivation yield, and broadening product offerings to address both medical and adult-use demand.

The company has made targeted acquisitions and asset purchases to consolidate operations, including investments in additional dispensary locations and cultivation infrastructure within Arizona. Its strategic investments emphasize organic growth and regulatory positioning rather than large-scale mergers. Emerging focus areas include operational automation, data-driven retail optimization, and product portfolio diversification, though data is inconclusive based on available public sources regarding material investments in cannabis-adjacent technologies.

Geographic Footprint

Vext Science’s operations are concentrated in Arizona, which serves as its primary operating region and the center of its cultivation, manufacturing, and retail activities. The company is headquartered in the United States and benefits from Arizona’s limited-license structure and established medical and adult-use cannabis markets.

While the company has evaluated opportunities in other U.S. jurisdictions, its operational footprint remains focused domestically. There is no verified evidence from public filings of material international operations or direct foreign investments as of the most recent reporting periods.

Leadership & Governance

Vext Science is led by an executive team with experience in cannabis operations, consumer products, and regulated industries. Leadership emphasizes compliance-driven growth, capital discipline, and vertical integration as core elements of its strategic vision.

Key executives include:

• Eric Offenberger – Chief Executive Officer
• Tom DeFrancesco – Chief Financial Officer
• Garrett Fortier – President
• Josh Green – Chief Operating Officer

The company operates under a board-governed structure consistent with publicly traded cannabis companies, with governance practices aligned to regulatory requirements in the U.S. cannabis sector.